The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.

Clin Epigenetics · 2016 · PMC4831179 · PMID 27081402

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

When we compared patients with high versus low JMJD6 expression, we observed a highly significant effect in samples with high Myc rather than low Myc expression (compare p values for left and right panels in Fig. 10a, c ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.